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Introduction
Treatment and prevention approaches for type 2 diabetes mellitus 
(T2DM) focus on achieving glycaemic control, in order to manage 
the disease and to prevent or slow down its complications. General 
management of diabetes consists of patient education, medical nutrition 
therapy, physical activity, and pharmacological therapy combined with 
oral hypoglycaemic agents or insulin [1].
Recently, the role of postprandial glycaemia (PPG) in overall glycaemic 
control and as a risk factor for cardiovascular complications has been 
discussed, as patients with good glycaemic control can show elevated 
postprandial hyperglycaemia (PPHG), which contributes significantly to 
the overall glycaemic control. In fact, the postprandial state is the norm 
for individuals who consume at least three meals a day at relatively fixed 
times, and during the postprandial period insulin secretion does not fully 
compensate for insulin resistance in T2DM [2]. Evidence suggests that 
PPHG seems to be common in T2DM patients and that neither adequate 
fasting plasma glucose levels [3] nor good overall glycaemic control, 
indicated by glycated haemoglobin (HbA1c) levels below or around 7% 
[4], are necessarily correlated with proper glycaemic control throughout 
the day. Some research showthat T2DM patients with a standardized diet 
experience hyperglycaemia more than nine hours per day and that even 
those patients with apparent good glycaemic control, measured by HbA1c 
below 7.0%, experienced PPHG for nearly six hours per day [5].
According to long term prospective cohort studies and clinical trials 
[6-8], there is a strong correlation between glycaemic control and the 
incidence of microvascular and macrovascular complications. The 
DECODE study, which analysed 13 prospective European cohort studies 
[9], suggests that fasting-glucose concentrations alone do not identify 
individuals at increased risk of death associated with hyperglycaemia. 
This study reports that during the follow-up period the largest number 
of excess deaths was observed in subjects who had impaired glucose 
tolerance but normal fasting blood glucose levels and concludes that 
the glucose level two hours after the start of a meal is a better predictor 
of deaths from all causes and cardiovascular disease than is fasting 
blood glucose. PPHG also seems associated with an increased risk of 
retinopathy, impaired cognitive function, and with increased carotid 
intima-media thickness. PPHG is also identified as a causal factor in 
oxidative stress, inflammation, and endothelial dysfunction [10]. Further 
evidence [3] suggests that PPG values one hour after a meal are predictive 
of all-cause mortality and reports that PPHG is associated with increased 
cardiovascular risk, independent of fasting hyperglycaemia.
PPHG seems most common after breakfast, possibly due to an elevated 
hepatic glucose output in the early morning. Data from 200 non–insulin-
treated patients with T2DM suggest that high plasma levels over morning 
periods after breakfast seem to occur independently of body mass index 
(BMI), HbA1c, therapy, and residual β-cell function [11, 12].
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patient’s clinical records. Weight and height were collected by standardized 
methods in order to compute BMI. The assessment of usual dietary intake 
was achieved by a 24-hour recall, plus questions regarding usual eating 
habits, both aided by the use of images representing food items and 
different portions [18].
In order to assess glucose response, all patients were offered a controlled 
breakfast, constructed according to the dietetic recommendations for 
patients with T2DM [19, 20], and obeying to usual eating habits in the 
region. The experimental meal had the following composition (Table 1).
The experimental breakfast corresponded to 24.6% of a daily caloric 
intake of 2000 Kcal. It was decided that the breakfast should account for at 
least 400 kcal, based on prediction equations that estimate a daily energy 
requirement of 2000 Kcal for adults over 50 years old with a lifestyle that 
includes only the light physical activity associated with typical day-to-day 
life [21], and considering that a nutritionally balanced breakfast should 
account for 20% to 25% of the daily energy intake [22-24].
In the day scheduled for data collection, patients were asked to follow 
their usual pharmacologic therapy and were offered the experimental 
breakfast between 8:00h A.M. and 9:00h A.M., according to individual 
preferences and usual breakfast intake hour. Subjects were asked to 
completely eat the all food items it contained, while seated, and without 
significant interruptions.
Glucose response to the experimental breakfast was assessed by the 
measurement of capillary blood glucose while the patients were in fasting, 
and in 30-minute intervals after the start of breakfast, up to 120 minutes 
after the meal. Five glucose measurements were collected for all patients 
with a portable blood glucose monitoring system (Freestyle Lite, MK-23, 
Abbot, USA). This particular handheld device has showed good analytical 
performance and clinical accuracy [25]. The same device was used for 
all patients to minimize variability and test strips came from the same 
batch. Before the data collection with each patient, a test measurement 
with the Freestyle Control Solution was conducted, in order to guarantee 
compatibility and precision with the discardable test strips. The blood 
samples for testing were obtained by puncture in the fingers of the left 
hand. Following the strictest safety and hygiene procedures. Patients were 
asked to remain seated during the course of the measurements in order to 
minimize physical activity, which could influence glucose response during 
the postprandial period.
All stages of this study obeyed the ethical rules for health sciences 
research as stated in the sixth revision of the Declaration of Helsinki, 
including an informed consent form which was signed by every patient 
during the briefing and recruitment.
Data were analysed with IBM-SPSS software version 20.0 (SPSS Inc., 
Chicago, IL, USA). Patient description and characterization were presented 
as mean values accompanied by standard deviations, and prevalence 
calculated as the percent of the total number of valid observations in each 
calculation.
The Kolmogorov-Smirnov test was used to assess adherence to the 
Normal distribution and Student’s t-test was computed for comparisons 
It is proposed [13] that two-hour postprandial plasma glucose should 
not exceed 9.0 mmol/l (162 mg/dl) or, based on the correlation with 
HbA1c values and aiming at a conservative target, that in order to achieve 
an HbA1c of 7%, the peak postprandial capillary blood glucose that 
usually occurs one hour to two hours after the start of a meal, should be 
below 180 mg/dl (10.0 mmol/l) [4]. Other data suggests that the difference 
between pre-prandial and post-prandial glycaemia should normally be 
between 30 and 50 mg/dl [14]. 
PPHG is still considered a complex topic [4], with limited available 
data, and although target values exist for postprandial glycaemia, most 
practitioners and clinicians rely solely on HbA1c and fasting glucose 
concentrations to evaluate and adjust therapeutic strategies [10, 15, 16]. 
Fating glucose and HbA1c are easy to measure, and the latter is especially 
used in the clinical setting to monitor diabetes, and to establish the degree of 
metabolic control. Deviation from individualized HbA1C targets prompts 
physicians to modify treatment strategies [16]. Nevertheless, by focusing 
solely on HbA1C or FPG levels, clinicians may miss opportunities to help 
patients to meet glycaemic targets, and minimize glucose variations which 
can have negative effects on long-term outcomes [2, 5].
These findings can imply that additional assessments should be 
undertaken in patients with T2DM, so as to fully evaluate metabolic 
control. Additionally, as the main predictor of PPG is the nutritional 
content of the meal, especially in carbohydrates, it can be proposed that 
the best option for regulating PPHG can be nutritional therapy [17], as 
it can bring several added benefits to the management of diabetes and 
its complications (e.g., weight reduction, improvement in lipid profile), 
without the side effects and costs of pharmacotherapy.
Based on the available evidence, the goal of this study was to analyse 
glucose response to a nutritionally controlled meal, in T2DM patients 
with and without proper glucose control. The specific objectives where: 
a) describe the association between PPG levels and HbA1c; b) analyse 
glucose response according to dietary, anthropometric and clinical 
variables.
Methods
We conducted a non-random trial in T2DM patients receiving health 
care in a Diabetes Clinic in the municipality of Faro, in the Portuguese 
region of the Algarve. Patients were invited to be a part of this study during 
their consultations and a date was set up according to their availability to 
proceed with data collection. The inclusion criteria for this study were age 
below 85 years and medical diagnosis of T2DM for at least 12 complete 
weeks, obtained by previous assessment and identification of one or more 
of the following: HbA1c ≥ 6.5%, FPG ≥ 126 mg/dl (7.0 mmol/l), 2h plasma 
glucose ≥ 200 mg/dl (11.1 mmol/l) during an oral glucose tolerance test, 
or presence of classic hyperglycaemia symptoms and a random plasma 
glucose ≥ 200 mg/dl (11.1 mmol/l). Patients were excluded if they were 
undergoing a pharmacotherapy regimen with insulin or any antidiabetic 
oral agents other than metformin, had a diagnosis of degenerative disorder 
of the central nervous system, or if they were following a lactose-free or 
gluten-free diet. Patients were recruited and coded as group 1 (G1) if they 
had been recorded as having an HbA1c of 7.0% or above in the 60 days 
prior to data collection, or as group 2 (G2) if they had been recorded as 
having HbA1c below 7.0% in the 60 days prior to data collection. The 
final study sample was composed by 66 patients, 32 in G1 and 34 in G2. 
Regarding gender distribution, 56% of the sample (n=37) were men and 
44% (n=29) were women. G1 was composed by 20 men (62.5%) and 
12 women (37.5%) and G2 was composed by 17 men (50%) and 17 
women (50%).
Patients were individually interviewed by a trained dietitian regarding 
their lifestyle and dietary habits and data were also collected from each 
Food Amount (g)
Energy 
(Kcal)
Protein 
(g)
Fat 
(g)
Carbohydrates 
(g)
Sugars 
(g)
Wheat 
bread 80 231.13 6.72 1.76 45.84 1.68
Ham 30 90.98 5.4 7.65 0.15 0.15
Milk 200 93.68 6.6 3.2 9.8 9.8
Apple 135 76.78 0.27 0.68 18.09 18.09
 Total 492.6 19 13.3 73.9 29.7
Table 1: Foods and nutritional values for the experimental breakfast
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Mean differences between pre-prandial and postprandial glucose 
were not correlated with age at diagnosis (rSpearman=-0.006, 
P=0.963) or at data collection (rSpearman=0.024, P=0.827), diabetes 
duration (rSpearman=0.108, P=0.387), HbA1c (rSpearman=-0.215, 
P=0.084), energy (rSpearman=0.013, P=0.916) or carbohydrate intake 
(rSpearman=-0.129, P=0.302), BMI(rSpearman=0.017, P=0.892), or 
frequency of glycaemia self-measurement (rSpearman=0.282, P=0.068). 
We also did not find gender differences in PPG at any of the measurement 
times either considering the total sample or considering only participants 
in G1 or G2 (p>0.05).
All mean values throughout the glucose monitoring were below 200 
mg/dl, even at 120 minutes, which corresponds to the diagnosis cut-off 
point for T2DM when using an oral glucose tolerance test [4].
No significant differences were found in the proportion of subjects 
above the 200 mg/dl threshold for glycaemia at 120 minutes after breakfast, 
and all subjects presented a PPG level above 140 mg/dl (Table 3).
Although we recorded a difference in mean BMI, the prevalence 
of overweight and obesity is statistically similar between groups (χ2 
(42)=9.34, P=0.063), as shown in figure 1.
Most participants self-measure their blood glucose weekly (39.4%) 
or at least once a day (34.8%). Nevertheless, we did not find statistically 
significant differences between G1 and G2 regarding self-measurement of 
blood glucose (Table 4).
between two groups. Correlations were analysed with Pearson or 
Spearman’s correlation coefficients and the chi-square test was used for 
group comparisons of qualitative variables.
Statistical significance in all procedures was determined by two-tailed 
analysis and set at 0.05.
Results
Table 2 presents data for clinical, dietary, anthropometric, and glucose 
response variables. Apart from the expected differences in HbA1c, there 
are also significant differences between G1 and G2 regarding age, age 
at diagnosis, BMI, total cholesterol, LDL cholesterol, and in the intake 
of sugars.
The analysis of the differences in glucose response to a mixed-meal 
containing 75 of carbohydrates shows that G1 and G2 do not significantly 
differ up to 120 minutes post-meal. According to the Student’s t-test 
(df=64), statistical significance for group differences is achieved in fasting 
glycaemia. Mean values up to 120 minutes after the experimental breakfast 
were similar in G1 and G2.
All but 4 participants (2 in G1 and 2 in G2) showed a mean difference 
between pre-prandial and postprandial glucose above 40 mg/dl. The mean 
difference was 57.1 mg/dl in G1 (SD=13.29 mg/dl) and 63.0 mg/dl in G2 
(SD=19.73 mg/dl), with the differences being statistically non-significant 
(t (64)=-1.4, P=0.159).
Variable All participants (N=66)
Group 1 
(N=32) Mean (SD)
Group 2 
(N=34)
P-value of Student’s 
t-test
HbA1c (%) 7.3 (1.62) 8.6 (1.40) 6.1 (0.51) < 0.001*
Age (years) 60.9 (7.96) 57.8 (7.08) 63.7 (7.79) 0.002*
Age when diagnosed (years) 54.5 (7.62) 51.8 (6.45) 57.0 (7.87) 0.005*
Disease duration (years) 6.2 (4.47) 6.0 (3.65) 6.4 (5.18) 0.73
BMI (kg/m2) 30.0 (4.28) 31.3 (4.44) 28.9 (3.85) 0.024**
HDL cholesterol (mg/dl) 48.6 (15.22) 48 (16.84) 49.3 (13.76) 0.735
Total cholesterol (mg/dl) 172.8 (35.25) 182.9 (33.17) 163.4 (35.01) 0.026**
Energy (kcal) 2258.3 (686.98) 2449 (781) 2079 (536) 0.030*
Protein (g) 88.3 (27.74) 91.2 (29.81) 85.6 (25.78) 0.419
Total carbohydrates (g) 267.5 (104.16) 292.5 (124.12) 243.9 (75.62) 0.062
Sugars (g) 107.4 (68.29) 128.9 (77.92) 87.2 (51.14) 0.012*
Fibre (g) 18.0 (8.37) 18.3 (8.73) 17.7 (8.13) 0.783
Lipids (g) 89.5 (34.10) 94.4 (36.95) 84.9 (31.03) 0.263
Glycaemia (mg/dl)
t0 minutes 119.1 (8.21) 122.3 (7.25) 116.1 (8.00) 0.001
*
t30 minutes 180.0 (27.16) 181.1 (25.70) 178.9 (28.80) 0.737
t60 minutes 172.1 (26.7) 173.1 (26.54) 171.1 (27.22) 0.77
t90 minutes 167.3 (24.72) 167.9 (23.21) 166.8 (26.41) 0.853
t120 minutes 179.3 (16.90) 179.4 (12.34) 179.1 (20.49) 0.939
Table 2: Mean differences between groups in clinical, anthropometric, and dietary variables
SD – Standard deviation
*Significant differences between groups at the 0.01 probability level
**Significant differences between groups at the 0.05 probability level
Glycaemia Group 1 (N=32) Group 2 (N=34) X2 test P-value
Fasting levels ≥ 126 mg/dl 34.40% 11.80% 0.028*
≥ 140 mg/dl 120 minutes after breakfast 100% 100% -
≥ 160 mg/dl 120 minutes after breakfast 100% 88.20% 0.065
≥ 200 mg/dl 120 minutes after breakfast 6.30% 11.80% 0.436
Table 3: Proportion of participants above selected glycaemia thresholds
*Significant differences between groups at the 0.05 probability level
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in order to analyse the role of different oral antidiabetic agents in PPG in 
subjects with adequate HbA1c.
The similarities in PPG between the subjects also add to the evidence 
that HbA1c, despite being considered an adequate predictor of glycaemic 
control that can be used for establishing a diagnosis, does not account 
for daily fluctuations of glucose [31-33]. The mean values for glucose 
excursions in both G1 (M=57.1 mg/dl, SD=13.29 mg/dl) and G2 (M=63.0 
mg/dl, SD=19.73 mg/dl) were significantly above the recommendations 
stating that this value should not exceed 40 mg/dl [10] and may imply an 
added risk for cardiovascular events [34]. Self-measure of blood glucose is 
the most appropriate way to identify PPHG and the results from this study 
show that patients should be empowered to overcome their low prevalence 
of glucose self-measure, as regular data of postprandial glycaemia can help 
to adjust diabetes care plans.
The major limitations of this study are related with the PPG assessment 
methods and with participant inclusion criteria. Due to financial and 
logistic restrictions, we were unable to use a continuous glucose monitor 
system or to assess insulin excursions. Although valid and a usual self-
monitoring method, capillary blood glucose measurements are not the 
gold standard for assessing PPG and this can be addressed in further 
studies. Additionally, in order to prevent biases in PPG analysis, our 
inclusion criteria implied that subjects had a similar pharmacotherapy 
regimen, which resulted in a reduced sampling universe and restricts the 
applicability of this study’s results to a specific subset of T2DM patients. 
The cross-sectional nature of our study did not allow us to assess variations 
in the diet, PPG patterns associated with other meals,or to confirm our 
results in other assays with the same participants.
Conclusions
Our data adds to the body of knowledge suggesting that patients which 
are considered as having a proper glucose control may be unaware that 
they exceed the recommended rise in PPG, and thus may be at a higher 
than expected risk for macro and microvascular events. This poses a 
challenge for dietetic and nutrition professionals, as meal plans for 
patients with diabetes should take into account the need to regulate PPG. 
Furthermore, our data also suggest that the prevalence of blood glucose 
self-monitoring is low and independent of glycaemic control. Thus, as 
self-monitoring is one of the most practical ways to detect PPG, providing 
immediate feedback on the effect of food and meals, efforts should be 
made to promote regular glucose self-monitoring among T2DM patients.
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